Resources

Publish Date
External ResourcesReports
An Unbalanced Proposal: Licensing Negotiation Groups for Wireless Technology in the Automotive Industry
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: U.S. Patent and Trademark Office
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on China and IP Theft
Public Comments
C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Public Comments
C4IP Response RE: OSTP RFI on Accelerating American Scientific Enterprise
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: the American Music Fairness Act of 2025
Letters
C4IP Letter to USTR RE: US-EU Trade Agreement
Public Comments
C4IP Comments RE: Revision to Rules of Practice Before PTAB (PTO-P-2025-0025)
Infographics & Fact Sheets
PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Letters
C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month
Resources:

Resources:

C4IP Letter to President Trump RE: Inauguration,

02/19/2025

Resources:

Resources:

Addressing Patent Myths,

12/19/2024

Resources:

Resources:

C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, and the Internet RE: Standard Essential Patents (SEPs),

12/17/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: the RESTORE Patent Rights Act,

12/17/2024

Resources:

Resources:

Joint High-Level Statement Valuing Creation, Invention, and Innovation: Re-booting Europe’s Potential,

11/07/2024

Resources:

Resources:

Patent Quality in the United States,

10/07/2024

Resources:

Resources:

C4IP Comments RE: Experimental Use Exception Request for Comments (PTO-C-2024-0023),

09/26/2024

Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: Hearing on The Medication Affordability and Patent Integrity Act,

09/25/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: PERA,

09/24/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: PERA, PREVAIL Act, and IDEA Act,

09/18/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: IDEA Act,

09/17/2024

Resources:

Resources:

C4IP Comments RE: 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence (PTO-P-2024-0026),

09/16/2024

Scroll to Top